HIV MEDICINE

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

Cardiovascular disease‐related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD)

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance

Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review

De‐simplifying single‐tablet antiretroviral treatments: uptake, risks and cost savings

Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV‐negative controls

Acute kidney injury in HIV‐infected patients: a critical review

Rapid initiation of antiretroviral therapy in those with newly diagnosed HIV infection in London, UK

Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel

Coronary artery calcium and intima‐media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV‐infected patients

Low incidence of acute rejection within 6 months of kidney transplantation in HIV‐infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial

Missed opportunities to prevent mother‐to‐child transmission of HIV in Italy

Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV‐monoinfected patients

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross‐sectional study

High‐risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV‐positive men who have sex with men

Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda

Summary of German‐Austrian HIV PrEP guideline

Post‐exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infections

Cause of death among HIV patients in London in 2016

Subclinical cardiovascular disease in HIV controller and long‐term nonprogressor populations

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

Recurrence after hospitalization for acute coronary syndrome among HIV‐infected and HIV‐uninfected individuals

Lost but not forgotten: A population‐based study of mortality and care trajectories among people living with HIV who are lost to follow‐up in Ontario, Canada

Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV‐1 with suppressed HIV RNA: derivation of a predictive score for virological failure

Does region of origin influence the timing and outcome of first‐line antiretroviral therapy in France?

Evaluation of kidney function in HIV‐infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine

Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones

Hepatic and renal toxicity and associated factors among HIV‐infected children on antiretroviral therapy: a prospective cohort study

CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia‐Pacific

Insulin resistance and intestinal integrity in children with and without HIV infection in Uganda

Author Index

‘How much raltegravir do you take?’ The answer may not be so obvious: an accidental finding from clinical practice

Response to: Fitzpatrick C, Lowe M, Richardson D. Sexually transmitted infection testing and rates in men who have sex with men (MSM) using HIV pre‐exposure prophylaxis. HIV Medicine 2019; https://doi.org/10.1111/hiv.12736 (published Online First: 16 March 2019)

Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study

Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery

Patterns of comorbidity and sociodemographic and psychosocial correlates among people living with HIV in South Carolina, USA

Latent tuberculosis infection screening in HIV‐infected patients: guidelines versus everyday practice in a UK HIV centre

Promoting oral HIV self‐testing via the internet among men who have sex with men in China: a feasibility assessment

Significant chronic airway abnormalities in never‐smoking HIV‐infected patients

Fatal measles as AIDS presentation in Italy

Secondary adrenal insufficiency from steroid use and co‐prescribing of cytochrome p450 3A4 inhibitors

Use of edoxaban for the treatment of venous thromboembolism in HIV‐infected patients

Updated direct costs of medical care for HIV‐infected patients within a regional population from 2006 to 2017

Letter to Editor: HIV medicine